What are the payment terms and lead time?

Payment terms are T/T or Western Union. Lead time is within 15 workdays in peak season or one month in off season.

Chinese Wolfberry Extract, Goji, Organic, Polysaccharide

Name: Chinese Wolfberry Extract, Goji, Organic, Polysaccharide
Brand: Zhejiang Fangge Pharmaceutical Industry Co., Ltd.
SKU: 1935161075

Zhejiang, ChinaZhejiang Fangge Pharmaceutical Industry Co., Ltd.

Negotiable

25 kg

Product profile

Customization

Available

Certification

ISO, HACCP, Sc

Assay Method

Model NO.

20%-50%

Application Form

Tablet, Capsule

Application

Food, Health Care Products

State

Powder

Extract Source

Goji

Shelf Life

3 Years

Storage Conditions

Cool and Dry

Color

Light Yellow to Brown

Weight (Kg)

Transport Package

Bucket

Specification

25/kg

Trademark

fangge

Origin

Zhejiang

Production Capacity

10t

Key features

Certified Quality: ISO, HACCP, GMP, and FDA registered with GMO-free and allergen-free standards.

High Purity Extract: Chinese Wolfberry Extract with 20%-50% Polysaccharide content via UV assay.

Factory Direct Supply: Own planting bases and deep processing R&D center in China.

Flexible Packaging: Available in 5kg or 25kg bags with airproof inner lining.

Global Export Experience: Exporting to USA, EU, and South Asia since 2003.

Custom OEM Service: Supports customized shelf life, storage, color, and weight options.

Company profile

Zhejiang Fangge Pharmaceutical Industry Co., Ltd.

Zhejiang, China

Business Type: Manufacturer/FactoryExport Year: 2003-12-16Average Response Time: ≤18hTerms of Payment: T/T, Western UnionInternational Commercial Terms(Incoterms): FOB, CIF

AI-Powered supplier vetting

SummaryZhejiang Fangge Pharmaceutical Industry Co., Ltd. is a China-based manufacturer/factory specializing in medicinal mushroom cultivation, research, production, marketing, and plant extracts. It reports GMP, ISO 9001, HACCP, FDA-related, organic, kosher, halal, and other certifications or credentials, although the exact scope and validity of several claims are not independently established in the provided information. The supplier has operated since 2003, exports through agents, and reports that exports account for 51%–70% of total sales. Its stated capabilities include 10 production lines, 6–10 R&D engineers, and 6–10 quality-control staff. Evidence confirms products supplied to at least one Vietnamese pharmaceutical buyer and identifies imports from Vietnam. No sufficient evidence is provided regarding after-sales service, customization, or financial credibility; registered capital data is excluded from this assessment.

Supplier typeThe supplier is explicitly identified as a Manufacturer/Factory and a limited company located in Zhejiang, China. Its stated product portfolio includes pharmaceuticals, health foods, agricultural products, ordinary foods, and daily chemical products, supporting classification as a manufacturing supplier.

CertificationsThe supplier states that it holds or has obtained Drug GMP certification, ISO 9001, HACCP, and a food production license, and also claims FDA, kosher, halal, and EU/US organic-related credentials. These statements provide explicit evidence of multiple certifications, although the documentation scope and current validity are not shown.

R&D capabilityThe supplier reports establishing a provincial high-tech enterprise R&D center for deep processing of fungi in 2007, conducting mushroom extract research and development, and employing 6–10 R&D engineers. These details explicitly support an established R&D capability focused on medicinal fungi and mushroom extracts.

Production capacityThe supplier states that it cultivates multiple mushroom varieties, ferments Cordyceps sinensis mycelia, performs extraction, and operates 10 production lines. Its reported GMP and food-related certifications, together with activities spanning cultivation, processing, production, and marketing, indicate substantial production capability.

Client casesThe supplier reports exporting products to many countries, with exports representing 51%–70% of total sales and export activity beginning in 2003. The provided records also associate it with CÔNG TY CỔ PHẦN DƯỢC PHẨM BOSTON VIỆT NAM and identify Vietnam as an import-related country, providing at least one identifiable buyer-related case.